Verdiva Bio has dosed the first patient in a Phase [...]

AB2 Bio will receive $30 million from Nippon Shinyaku after [...]

ViiV Healthcare’s long-acting injectable Cabenuva has demonstrated superior virologic outcomes [...]

Caristo Diagnostics’ CaRi-Heart technology has received US FDA De Novo [...]

A European survey of more than 1,900 people living with [...]

ThinkSono has received US FDA 510(k) clearance for ThinkSono Guidance, [...]

ProMIS Neurosciences has reported six-month interim safety and biomarker data [...]

HAYA Therapeutics has received FDA Fast Track designation for HTX-001, [...]

Amorphical has completed patient enrolment in a Phase 2 trial [...]

Claris Biotherapeutics has raised $118 million in a Series B [...]